Competition: EU
Belgium
6 years ranked
Provided by Covington & Burling LLP
Sibel Yilmaz advises on all aspects of competition law, foreign investment and foreign subsidies screening, with a focus on the life sciences, technology and private equity sectors.
Sibel has particular expertise in the life sciences sector and has been involved in some of the industry's most high profile matters in recent years, including representing Novartis on its $30 billion acquisition of GSK’s oncology business, advising Takeda on its sale of certain respiratory products to AstraZeneca and representing clients in several investigations relating to alleged excessive prices and other non-competitive practices in the life science sector.
Provided by Chambers
Sibel Yilmaz has experience in the notification of mergers and foreign direct investments, and is able to assist clients with FSR-related questions. She demonstrates particular understanding of the life sciences sector.
Provided by Chambers
Sibel Yilmaz is very pragmatic and solution oriented. She is able to put herself in the client's shoes and understand their needs.
Sibel Yilmaz is a very talented lawyer who takes her client's interests to heart. She is truly a partner to her clients.
Sibel Yilmaz is a truly excellent and well-rounded advisor. She provides solid and pragmatic advice on complex topics that enables the client's business to operate in a compliant way.
Chambers is the leading data and intelligence partner for the legal sector.